#Actinic keratosis

[credenceresearchdotblog]

The global market for actinic keratosis is expected to grow from its estimated USD 6514.2 million in 2023 to USD 9933.73 million in 2032 at a compound annual growth rate (CAGR) of 4.80% between 2024 and 2032.Actinic keratosis (AK), also known as solar keratosis, is a common skin condition characterized by rough, scaly patches on the skin caused by excessive exposure to ultraviolet (UV) radiation. As the precursor to squamous cell carcinoma, a type of skin cancer, early detection and treatment of AK are critical. The global actinic keratosis market has been growing significantly due to rising awareness about skin cancer, advancements in treatment options, and increasing prevalence of the condition.

Browse the full report at https://www.credenceresearch.com/report/actinic-keratosis-market

Market Overview

The actinic keratosis market is segmented based on treatment types, including topical treatments, procedural treatments, and combination therapies. Topical treatments involve the application of medicated creams or gels directly to the affected area. Procedural treatments include cryotherapy, laser therapy, and photodynamic therapy (PDT). Combination therapies integrate multiple treatment approaches to improve efficacy.

Topical Treatments

Topical treatments are often the first line of defense against actinic keratosis. Popular medications include 5-fluorouracil (5-FU), imiquimod, diclofenac, and ingenol mebutate. These treatments are designed to target and eliminate the abnormal skin cells. The ease of application and non-invasive nature of topical treatments make them a preferred choice among patients. However, they can cause side effects such as redness, swelling, and discomfort at the application site.

Procedural Treatments

Procedural treatments, especially cryotherapy, are widely used for AK. Cryotherapy involves freezing the lesions with liquid nitrogen, leading to cell death and shedding of the damaged skin. Laser therapy uses focused light to remove or destroy the abnormal skin cells, while PDT combines a photosensitizing agent with light exposure to target and destroy the lesions. These methods are often chosen for patients with multiple or large lesions, or when topical treatments are not effective.

Combination Therapies

Combination therapies are becoming increasingly popular as they offer enhanced treatment efficacy and better patient outcomes. For instance, combining cryotherapy with topical 5-FU or imiquimod has shown higher clearance rates compared to monotherapy. The integration of different treatment modalities addresses the limitations of individual therapies and reduces the recurrence of lesions.

Market Dynamics

The actinic keratosis market is driven by several factors:

1. Rising Prevalence: Increased UV exposure due to outdoor activities, thinning ozone layer, and longer life expectancy contribute to the growing incidence of actinic keratosis. Older adults are particularly at risk, with studies showing that over half of people aged 70 and above have at least one AK lesion.

2. Awareness and Screening Programs: Public health initiatives and awareness campaigns have improved early detection rates of actinic keratosis. Regular skin screenings and educational programs encourage people to seek medical attention for suspicious lesions, thereby driving the demand for AK treatments.

3. Technological Advancements: Innovations in treatment modalities, such as advanced laser therapies and improved formulations of topical medications, have enhanced the effectiveness and safety of actinic keratosis treatments. Development of new drugs and combination therapies continues to expand the market.

4. Regulatory Approvals: Regulatory approvals of new treatment options by authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) facilitate market growth. For example, the approval of new topical agents or combination therapies opens up new avenues for patient care.

Challenges and Opportunities

Despite the positive market outlook, the actinic keratosis market faces certain challenges. High treatment costs and limited access to healthcare in developing regions can hinder market growth. Additionally, the side effects associated with some treatments may lead to patient non-compliance.

However, the market presents several opportunities. Increasing investments in research and development for novel treatments, expanding healthcare infrastructure in emerging economies, and growing adoption of telemedicine for remote diagnosis and management of actinic keratosis are key factors that can drive future market expansion.

Key Players

Almirall, S.A.

Bausch Health Companies Inc.

Perrigo Company plc.

Sun Pharmaceutical Industries Ltd.

Hill Dermaceuticals, Inc.

Spear Pharmaceuticals

Tolmar Pharmaceuticals, Inc.

Bioforntera AG

Cipher Pharmaceuticals Inc.

Vidac

Athenex, Inc.

3M

Mayne Pharma Group Limited

Others

Segmentation

By Treatment Type

Topical Medications

Photodynamic Therapy (PDT)

Cryotherapy

Laser Therapy

Chemical Peels

By Distribution Channel

Hospitals and Clinics

Dermatology Centers

Retail Pharmacies

Online Retail

By Prescription Status

Prescription Medications

Over-the-counter (OTC) Products

By Patient Type

Outpatient Treatment

Self-administered Treatment

By Age Group

Adults

Elderly

By Gender

Male

Female

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/actinic-keratosis-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[mcatmemoranda]

A lump on the back could be a sebaceous cyst. Had a pt with one today. They are not dangerous. Can be removed for cosmetic reasons. My pt has had hers x20 years! I always forget the term "actinic keratosis" for some reason, but don't forget "seborrheic keratosis ." The former is a pre-cancerous flaky lesion that you can freeze off. I froze my pt's off with liquid nitrogen.

[businessindustry]

Actinic Keratosis Treatment Market Future Overview and Share, Forecast 2032

The Reports and Insights, a leading market research company, has recently releases report titled “Actinic Keratosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Actinic Keratosis Treatment Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Actinic Keratosis Treatment Market?

The global actinic keratosis treatment market size reached US$ 5.1 billion in 2023. Looking forward, Reports and Insights expects the market to reach US$ 9.2 billion in 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032.

What are Actinic Keratosis Treatment?                                                                                                                                                                            

Actinic Keratosis (AK) is a rough, scaly patch on the skin resulting from prolonged sun exposure, considered a precancerous condition that can develop into squamous cell carcinoma if left untreated. Treatment options include cryotherapy (freezing the lesion with liquid nitrogen), topical medications such as fluorouracil, imiquimod, or diclofenac, and photodynamic therapy, which uses a photosensitizing agent followed by light exposure. Additional treatments include laser therapy, chemical peels, and surgical removal. The choice of treatment depends on the number, size, and location of the lesions, as well as patient preference and tolerance.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2215

What are the growth prospects and trends in the Actinic Keratosis Treatment industry?

The actinic keratosis (AK) treatment market growth is driven by various factors and trends. The actinic keratosis (AK) treatment market is growing due to the increasing incidence of AK from prolonged sun exposure and an aging population. Key treatments include cryotherapy, topical medications (such as fluorouracil, imiquimod, and diclofenac), photodynamic therapy, laser therapy, chemical peels, and surgical options. The market is marked by ongoing innovations in treatment techniques and the development of more effective, less invasive therapies. North America leads the market due to high awareness and advanced healthcare infrastructure, with significant growth also observed in Europe and Asia-Pacific. Market expansion is driven by rising healthcare expenditures, increased patient awareness, and advancements in dermatological treatments. Hence, all these factors contribute to actinic keratosis (AK) treatment market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

By Treatment Type

Photodynamic therapy

Cryosurgery

Chemical peel

Laser therapy

Curettage

Topical Therapies

5-fluorouracil (5-FU)

Diclofenac

Imiquimod

Tirbanibulin

North America

United States

Canada

Europe

Germany

United Kingdom

France

Italy

Spain

Russia

Poland

Benelux

Nordic

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

ASEAN

Australia New Zealand

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Middle East Africa

Saudi Arabia

South Africa

United Arab Emirates

Israel

Rest of MEA

Who are the key players operating in the industry?

The report covers the major market players including:

Sun Pharmaceutical Industries Ltd

Biofrontera

Bausch Health Companies Inc.

Almirall

LEO Pharma Inc.

Cipher Pharmaceuticals Inc.

Pierre Fabre Pharmaceuticals, Inc.

Galderma S.A.

3M Company

Taro Pharmaceutical Industries Ltd

View Full Report: https://www.reportsandinsights.com/report/Actinic Keratosis Treatment-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

Reports and Insights Business Research Pvt. Ltd. 1820 Avenue M, Brooklyn, NY, 11230, United States Contact No: +1-(347)-748-1518 Email: sales@reportsandinsights.com Website: https://www.reportsandinsights.com/ Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/ Follow us on twitter: https://twitter.com/ReportsandInsi1

[yaminerua]

the thing on my dad’s nose is really stressing me out and I know waiting times are fucked but god the roiling anxiety at all times worrying about it makes me feel like I’m going to explode;; I just hope when it does get seen to eventually that it’ll be ok

[justcallthenurse]

…shaved for the first time in 6 days😩😩 tomorrow will be day 7, 2 more applications … looks clean … but it’s what down deep that counts.

[mitalipingale]

https://carbonfacesocial.org/blogs/61426/Actinic-Keratosis-Treatment-Market-Share-Overview-Competitive-Analysis-and-Forecast

The Actinic Keratosis Treatment Market in 2023 is US$ 5.79 billion, and is expected to reach US$ 10.11 billion by 2031 at a CAGR of 7.20%.

[soumyafwr]

https://menagerie.media/index.php?link1=read-blog&id=39714_actinic-keratosis-treatment-market-size-share-and-forecast-2031.html

Actinic Keratosis Treatment Market Size, Share and Forecast 2031

[lalsingh228-blog]

Actinic Keratosis Treatment Market Projected to Show Strong Growth

Advance Market Analytics published a new research publication on "Actinic Keratosis Treatment Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Actinic Keratosis Treatment market was mainly driven by the increasing R&D spending across the world.

Get Free Exclusive PDF Sample Copy of This Research @ https://www.advancemarketanalytics.com/sample-report/63673-global-actinic-keratosis-treatment-market The Actinic Keratosis Treatment Market report covers extensive analysis of the key market players, along with their business overview, expansion plans, and strategies. The key players studied in the report include: LEO Pharma A/S (Denmark), Almirall, S.A. (Spain), Biofrontera, Inc. (Germany), Nestlé S.A. (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Novartis International AG (Switzerland), 3M Pharmaceuticals Inc (United States), Hill Dermaceuticals, Inc. (United States), Mylan N.V. (United States), DUSA Pharmaceuticals (United States), Definition: Actinic keratosis is the most prevalent class of precancerous skin lesions will help to boost global Actinic Keratosis Treatment market in the forecasted period.

An actinic keratosis (AK), also known as solar keratosis, is a crusty, scaly growth caused by damage from exposure to ultraviolet (UV) radiation. The impending launch of pipeline products, combined with the research and development of novel treatments with improved efficacy, convenient dosage, and reduced cost, indicates a promising future for the actinic keratosis treatment market. The following fragment talks about the Actinic Keratosis Treatment market types, applications, End-Users, Deployment model etc. A thorough analysis of Actinic Keratosis Treatment Market Segmentation: by Therapy (Topical, Surgery, Photodynamic Therapy), Drug Class (Nucleoside Metabolic Inhibitors, NSAIDs, Immune Response Modifiers, Photo enhancers, Others), End User (Hospitals, Private Clinics, Homecare, Others) Actinic Keratosis Treatment Market Drivers:

Increasing Prevalence Of Actinic Keratosis Is Higher In Western Countries

The Growing Acceptance Of Minimally Invasive Therapeutic Procedures

Actinic Keratosis Treatment Market Trends:

The Rise in Disease Prevalence, Aided By Environmental Factors, Such As Ozone Depletion and Excessive Sun Exposure

Favorable Reimbursement Policies to Expand The Affordability

Actinic Keratosis Treatment Market Growth Opportunities:

Awareness Programs By Non-Profit Organizations To Fuel Sales Of Actinic Keratosis Treatment

As the Actinic Keratosis Treatment market is becoming increasingly competitive, it has become imperative for businesses to keep a constant watch on their competitor strategies and other changing trends in the Actinic Keratosis Treatment market. Scope of Actinic Keratosis Treatment market intelligence has proliferated to include comprehensive analysis and analytics that can help revamp business models and projections to suit current business requirements. We help our customers settle on more intelligent choices to accomplish quick business development. Our strength lies in the unbeaten diversity of our global market research teams, innovative research methodologies, and unique perspective that merge seamlessly to offer customized solutions for your every business requirement. Have Any Questions Regarding Global Actinic Keratosis Treatment Market Report, Ask Our Experts@ https://www.advancemarketanalytics.com/enquiry-before-buy/63673-global-actinic-keratosis-treatment-market Strategic Points Covered in Table of Content of Global Actinic Keratosis Treatment Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Actinic Keratosis Treatment market

Chapter 2: Exclusive Summary and the basic information of the Actinic Keratosis Treatment Market.

Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Actinic Keratosis Treatment

Chapter 4: Presenting the Actinic Keratosis Treatment Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying the by Type, End User and Region/Country 2018-2022

Chapter 6: Evaluating the leading manufacturers of the Actinic Keratosis Treatment market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2023-2028)

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Finally, Actinic Keratosis Treatment Market is a valuable source of guidance for individuals and companies. Read Detailed Index of full Research Study at @ https://www.advancemarketanalytics.com/reports/63673-global-actinic-keratosis-treatment-market What benefits does AMA research study is going to provide?

Latest industry influencing trends and development scenario

Open up New Markets

To Seize powerful market opportunities

Key decision in planning and to further expand market share

Identify Key Business Segments, Market proposition & Gap Analysis

Assisting in allocating marketing investments

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia. Contact US : Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 sales@advancemarketanalytics.com

[marketsizereports]

An Overview of the Actinic Keratosis Pipeline Drugs Market: Trends and Insights

Actinic keratosis (AK) is a common skin condition characterized by rough, scaly patches or lesions caused by long-term sun exposure. The treatment of AK often involves topical medications and occasionally procedures such as cryotherapy or photodynamic therapy. The pipeline drugs market for actinic keratosis is continuously evolving, driven by advancements in medical research and a growing demand for effective and less invasive treatments.

For more target insights, download a free report sample

Here's an overview of the trends and insights in the actinic keratosis pipeline drugs market:

1. Advancements in Topical Therapies:

Trend: There is ongoing research and development focused on improving the efficacy and tolerability of topical treatments for AK.

Insight: New formulations and combinations of topical drugs are being developed to enhance patient compliance and treatment outcomes.

2. Immune Modulators:

Trend: Immune modulators, such as immune checkpoint inhibitors, are being investigated for their potential in treating AK.

Insight: These therapies aim to harness the body's immune system to target and eliminate precancerous cells, offering a novel approach to AK treatment.

3. Targeted Therapies:

Trend: Targeted therapies that specifically inhibit the growth of precancerous cells are gaining attention.

Insight: These therapies aim to reduce the side effects associated with traditional treatments while effectively treating AK lesions.

4. Combination Therapies:

Trend: Researchers are exploring combination therapies that use multiple drugs to improve treatment outcomes.

Insight: Combining drugs with different mechanisms of action can enhance the effectiveness of AK treatment and reduce the risk of resistance.

5. Novel Delivery Methods:

Trend: Innovative drug delivery methods, such as nanoparticles and microneedles, are being studied to optimize drug absorption and penetration.

Insight: These delivery methods aim to enhance the distribution of drugs within AK lesions, improving therapeutic results.

6. Personalized Medicine:

Trend: Advances in genomics and biomarker research are paving the way for personalized medicine approaches in AK treatment.

Insight: Tailoring treatment plans to an individual's genetic and molecular profile can optimize therapeutic outcomes and reduce unnecessary side effects.

7. Minimizing Side Effects:

Trend: Drug developers are focused on formulating medications with fewer side effects to improve patient tolerability.

Insight: Minimizing side effects is essential to enhancing patient compliance and overall treatment satisfaction.

8. Telemedicine and Remote Monitoring:

Trend: The adoption of telemedicine and remote monitoring tools has increased, allowing dermatologists to monitor AK patients more closely.

Insight: Telemedicine provides a convenient way for patients to receive ongoing care and follow-up, ensuring treatment adherence.

9. Regulatory Environment:

Trend: Stringent regulatory requirements by agencies such as the FDA influence the development and approval of AK drugs.

Insight: Drug developers must navigate complex regulatory pathways to bring new treatments to market, ensuring safety and efficacy.

In summary, the actinic keratosis pipeline drugs market is characterized by ongoing research and innovation aimed at improving treatment outcomes, minimizing side effects, and enhancing patient compliance. As the understanding of AK and its treatment options continues to evolve, patients can expect more effective and personalized therapies in the future. It's important for individuals at risk of AK to engage with healthcare professionals, practice sun-safe behaviors, and stay informed about the latest developments in AK treatment.

[oceanskinadnvein]

What is Actinic Keratosis

Actinic keratosis, also known as solar keratosis, is a common skin condition that affects people who have been exposed to the sun’s harmful ultraviolet (UV) rays. It is characterized by rough, scaly patches or lesions that typically occur on sun-exposed areas such as the face, scalp, hands, and arms.

Actinic keratosis is considered a precancerous condition because it can sometimes develop into a type of skin cancer called squamous cell carcinoma. While not all actinic keratoses will turn into cancer, it is important to have them evaluated by a dermatologist to determine the best course of treatment.

Risk factors for actinic keratosis include prolonged sun exposure, fair skin, a history of sunburns, and a weakened immune system. It is most commonly seen in individuals over the age of 40, although it can occur in younger individuals as well.

Symptoms of actinic keratosis may include a rough, scaly patch of skin that may be pink, red, or brown in color. The patch may be flat or slightly raised, and may feel dry or itchy. In some cases, the patch may form a hard, horn-like growth.

Treatment for actinic keratosis typically involves the removal of the affected area. This may be done using cryotherapy (freezing the lesion with liquid nitrogen), curettage (scraping the lesion off with a surgical tool), or topical medications such as imiquimod or fluorouracil. In some cases, a combination of these treatments may be used. Know more about Actinic Keratosis please visit our blog page : https://www.oceanskinandvein.com/what-is-actinic-keratosis/

[businesspointnews]

Actinic Keratosis Treatment Market Research Report 2023-2028 | Healthcare Industry Report

IMARC Group has recently released a new research study titled “Actinic Keratosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios. Actinic Keratosis Treatment Market Report…

[businessindustry]

Actinic Keratosis Treatment Market Future Demands, Forecast 2032

The Reports and Insights, a leading market research company, has recently releases report titled “Actinic Keratosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global Actinic Keratosis Treatment Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the Actinic Keratosis Treatment Market?

The global actinic keratosis treatment market size reached US$ 5.1 billion in 2023. Looking forward, Reports and Insights expects the market to reach US$ 9.2 billion in 2032, exhibiting a growth rate (CAGR) of 6.8% during 2024-2032.

What are Actinic Keratosis Treatment?                                                                                                                                                                            

Treatment for actinic keratosis involves employing medical interventions to manage precancerous skin lesions triggered by prolonged sun exposure. Methods include topical applications like creams or gels containing medications that induce skin peeling or modulate immune responses, cryotherapy to freeze off lesions, photodynamic therapy utilizing light activation of photosensitizing agents, and in certain instances, surgical excision for deeper or stubborn lesions. Timely intervention is critical to prevent these lesions from progressing into skin cancer, underscoring the importance of regular dermatological assessment and treatment for effective management of actinic keratosis.

Request for a sample copy with detail analysis: https://www.reportsandinsights.com/sample-request/2215

What are the growth prospects and trends in the Actinic Keratosis Treatment industry?

The actinic keratosis treatment market growth is driven by various factors and trends.  The market for treating actinic keratosis includes a variety of medical interventions designed to manage precancerous skin lesions resulting from sun exposure. These treatments encompass topical therapies such as creams and gels containing agents that promote skin peeling or modify immune responses, cryotherapy for freezing off lesions, photodynamic therapy utilizing light and photosensitizing agents, and surgical procedures for more severe cases. Market growth is fueled by rising awareness of skin cancer risks and the need for effective treatments, with ongoing advancements in therapeutic methods and product offerings expanding treatment options globally. Hence, all these factors contribute to actinic keratosis treatment market growth.

What is included in market segmentation?

The report has segmented the market into the following categories:

By Treatment Type

Photodynamic therapy

Cryosurgery

Chemical peel

Laser therapy

Curettage

Topical Therapies

5-fluorouracil (5-FU)

Diclofenac

Imiquimod

Tirbanibulin

North America

United States

Canada

Europe

Germany

United Kingdom

France

Italy

Spain

Russia

Poland

Benelux

Nordic

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

ASEAN

Australia New Zealand

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Middle East Africa

Saudi Arabia

South Africa

United Arab Emirates

Israel

Rest of MEA

Who are the key players operating in the industry?

The report covers the major market players including:

Sun Pharmaceutical Industries Ltd

Biofrontera

Bausch Health Companies Inc.

Almirall

LEO Pharma Inc.

Cipher Pharmaceuticals Inc.

Pierre Fabre Pharmaceuticals, Inc.

Galderma S.A.

3M Company

Taro Pharmaceutical Industries Ltd

View Full Report: https://www.reportsandinsights.com/report/Actinic Keratosis Treatment-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

Reports and Insights consistently mееt international benchmarks in the market research industry and maintain a kееn focus on providing only the highest quality of reports and analysis outlooks across markets, industries, domains, sectors, and verticals. We have bееn catering to varying market nееds and do not compromise on quality and research efforts in our objective to deliver only the very best to our clients globally.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

Reports and Insights Business Research Pvt. Ltd. 1820 Avenue M, Brooklyn, NY, 11230, United States Contact No: +1-(347)-748-1518 Email: sales@reportsandinsights.com Website: https://www.reportsandinsights.com/ Follow us on LinkedIn: https://www.linkedin.com/company/report-and-insights/ Follow us on twitter: https://twitter.com/ReportsandInsi1

[stickyleadybloger]

https://worlegram.com/read-blog/105599

Actinic Keratosis Treatment Market Trends, Growth Factors, Share and Demand by Forecast to 2030

[reportstores]

Verisante Presents Positive Aura Clinical Study Data

Positive results from the Aura clinical study at the University of British Columbia (UBC), Canada, have been released by Verisante Technology.

Malignant melanoma, squamous cell carcinoma, basal cell carcinoma, Actinic Keratosis Clinical Trial, and benign conditions that can visually mimic skin cancer were the primary subjects of the study.

Over 1,000 lesions from 848 patients were measured by the authors of the study. The analysis revealed that Aura distinguished between all major skin cancers and benign lesions with a sensitivity of 99 percent and a specificity of 17 percent. The specificity of Aura increased to 41% at a sensitivity of 95%. Aura had a sensitivity of 99% and a specificity of 15% when comparing benign lesions to melanoma. According to the study's authors, specificity increased to 38% at a sensitivity of 95%. A device that can detect melanoma used to have to have an endpoint sensitivity of 95%, according to the FDA.

According to Thomas Braun, president and CEO of Verisante, these clinical results demonstrate that Aura will significantly improve skin cancer detection. According to our assessment of UBC's statistical analysis, the Aura will save lives and money. According to the findings, "using the Aura to help guide clinical evaluations could potentially reduce the number of unnecessary biopsies by 50 to 100 percent," he added.

The Aura was created as a tool to help doctors evaluate suspicious skin lesions for a possible diagnosis of skin cancer or a benign condition. The skin is biochemically analyzed using the non-invasive optical system, which provides immediate results using Raman spectroscopy. The device will assist in automating the current diagnosis procedure, enabling the rapid scanning of 20 to 40 skin lesions in individuals at risk, thereby enhancing patient comfort and outcomes.

Verisante Aura is legal to sell in Australia, Europe, and Canada.